IRIS Accounts Production v23.4.0.336 14273627 Board of Directors 3.8.22 31.8.23 31.8.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh142736272022-08-02142736272023-08-31142736272022-08-032023-08-31142736272022-08-0214273627ns15:EnglandWales2022-08-032023-08-3114273627ns14:PoundSterling2022-08-032023-08-3114273627ns10:Director12022-08-032023-08-3114273627ns10:PrivateLimitedCompanyLtd2022-08-032023-08-3114273627ns10:SmallEntities2022-08-032023-08-3114273627ns10:AuditExempt-NoAccountantsReport2022-08-032023-08-3114273627ns10:SmallCompaniesRegimeForDirectorsReport2022-08-032023-08-3114273627ns10:SmallCompaniesRegimeForAccounts2022-08-032023-08-3114273627ns10:FullAccounts2022-08-032023-08-3114273627ns10:Director22022-08-032023-08-3114273627ns10:RegisteredOffice2022-08-032023-08-3114273627ns5:CurrentFinancialInstruments2023-08-3114273627ns5:ShareCapital2023-08-3114273627ns5:RetainedEarningsAccumulatedLosses2023-08-3114273627ns5:FurnitureFittings2022-08-032023-08-3114273627ns5:ComputerEquipment2022-08-032023-08-3114273627ns5:FurnitureFittings2023-08-3114273627ns5:ComputerEquipment2023-08-31
REGISTERED NUMBER: 14273627 (England and Wales)















Unaudited Financial Statements

for the Period 3 August 2022 to 31 August 2023

for

Ambear Medical Ltd

Ambear Medical Ltd (Registered number: 14273627)






Contents of the Financial Statements
for the Period 3 August 2022 to 31 August 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Ambear Medical Ltd

Company Information
for the Period 3 August 2022 to 31 August 2023







DIRECTORS: D Murray-White
A Murray-White





REGISTERED OFFICE: 109 Lillie Road
Fulham
London
SW6 7SX





REGISTERED NUMBER: 14273627 (England and Wales)





ACCOUNTANTS: NT Accountancy
Chartered Accountants
43 Lynton Mead
London
N20 8DG

Ambear Medical Ltd (Registered number: 14273627)

Balance Sheet
31 August 2023

Notes £    £   
FIXED ASSETS
Tangible assets 4 1,514

CURRENT ASSETS
Debtors 5 1,512
Cash at bank 113,750
115,262
CREDITORS
Amounts falling due within one year 6 94,864
NET CURRENT ASSETS 20,398
TOTAL ASSETS LESS CURRENT
LIABILITIES

21,912

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 21,812
SHAREHOLDERS' FUNDS 21,912

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 August 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 August 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Ambear Medical Ltd (Registered number: 14273627)

Balance Sheet - continued
31 August 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 March 2024 and were signed on its behalf by:





D Murray-White - Director


Ambear Medical Ltd (Registered number: 14273627)

Notes to the Financial Statements
for the Period 3 August 2022 to 31 August 2023

1. STATUTORY INFORMATION

Ambear Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Computer equipment - 25% on reducing balance

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
Additions 1,126 790 1,916
At 31 August 2023 1,126 790 1,916
DEPRECIATION
Charge for period 225 177 402
At 31 August 2023 225 177 402
NET BOOK VALUE
At 31 August 2023 901 613 1,514

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 1,512

Ambear Medical Ltd (Registered number: 14273627)

Notes to the Financial Statements - continued
for the Period 3 August 2022 to 31 August 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Corporation Tax 29,818
Social security and other taxes 9,556
Directors' current accounts 53,990
Accrued expenses 1,500
94,864